Cointime

Millendo Therapeutics

company

About

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.

  • 11 - 50

Highlights

Total Funding Amount
$30M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$30M
Industries
Biotechnology,Life Science,Therapeutics
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases where current therapies do not exist or are insufficient. Millendo seeks to create distinct and transformative treatments where there is a significant unmet medical need.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$30M
Millendo Therapeutics has raised a total of $30M in funding over 2 rounds. Their latest funding was raised on Aug 9, 2018 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 9, 2018 Series Unknown $30M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Millendo Therapeutics is funded by 1 investors. InnoBio Fund are the most recent investors.
Investor Name Lead Investor Funding Round
InnoBio Fund — Series Unknown
Cointime
เนื้อหา
บริษัท